Patents by Inventor Katrien REMAUT

Katrien REMAUT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250387344
    Abstract: A composition includes particles for use in a method for the treatment of a vitreous disease or a vitreous disorder as a light sensitizing agent. Each particle has a surface selected for or adapted for providing mobility of the particle in the vitreous and for binding to collagen aggregates, such as floaters.
    Type: Application
    Filed: August 26, 2025
    Publication date: December 25, 2025
    Inventors: Stefaan DE SMEDT, Felix SAUVAGE, Kevin BRAECKMANS, Katrien REMAUT, Marie-José TASSIGNON, Juan FRAIRE, Jerry SEBAG
  • Patent number: 12419844
    Abstract: A composition includes particles for use in a method for the treatment of a vitreous disease or a vitreous disorder as a light sensitizing agent. Each particle has a surface selected for or adapted for providing mobility of the particle in the vitreous and for binding to collagen aggregates, such as floaters.
    Type: Grant
    Filed: October 8, 2019
    Date of Patent: September 23, 2025
    Assignees: UNIVERSITEIT GENT, UNIVERSITEIT ANTWERPEN, UNIVERSITAIR ZIEKENHUIS ANTWERPEN
    Inventors: Stefaan De Smedt, Felix Sauvage, Kevin Braeckmans, Katrien Remaut, Marie-José Tassignon, Juan Fraire, Jerry Sebag
  • Publication number: 20230293348
    Abstract: The invention concerns a dye for use in a method of photoporation of the inner limiting membrane (ILM) of an eye in a subject. Preferably, the method comprises: administering the dye to the vitreous chamber of the eye of the subject; and irradiating at least part of the ILM of the eye of the subject, thereby photoporating at least part of the ILM in the subject. The invention further relates to a dye and optionally a therapeutic agent for use in a method of treating a retinal disease or a choroidal disease of an eye in a subject.
    Type: Application
    Filed: July 9, 2021
    Publication date: September 21, 2023
    Applicant: UNIVERSITEIT GENT
    Inventors: Katrien REMAUT, Karen PEYNSHAERT, Stefaan DE SMEDT, Kevin BRAECKMANS
  • Publication number: 20230256095
    Abstract: The invention concerns a dye for use in a method of treating a vitreous opacity-related disease in a subject. The method preferably comprises administering the dye to the vitreous body of an affected eye of the subject; and irradiating at least part of the vitreous opacity, thereby inducing destruction of the vitreous opacity in the subject. The invention further relates to the use of a dye for photodestruction of a vitreous opacity in an eye of a subject, and to a method of photodestruction of a vitreous opacity in an eye of a subject, the method comprising: administering a dye to the vitreous body of the eye of the subject; and irradiating at least part of the vitreous opacity, thereby inducing destruction of the vitreous opacity of the subject.
    Type: Application
    Filed: July 9, 2021
    Publication date: August 17, 2023
    Applicant: UNIVERSITEIT GENT
    Inventors: Félix SAUVAGE, Stefaan DE SMEDT, Kevin BRAECKMANS, Katrien REMAUT, Aranit HARIZAJ
  • Publication number: 20210338595
    Abstract: A composition includes particles for use in a method for the treatment of a vitreous disease or a vitreous disorder as a light sensitizing agent. Each particle has a surface selected for or adapted for providing mobility of the particle in the vitreous and for binding to collagen aggregates, such as floaters.
    Type: Application
    Filed: October 8, 2019
    Publication date: November 4, 2021
    Inventors: Stefaan DE SMEDT, Felix SAUVAGE, Kevin BRAECKMANS, Katrien REMAUT, Marie-José TASSIGNON, Juan FRAIRE, Jerry SEBAG